Sign in
CompletedNo phase

Visual Performance of Patients Implanted With a Multifocal IOL

Key facts

Who runs it
Carl Zeiss Meditec AG
Where
Germany and Spain3 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
69 people enrolled
Started
31 Oct 2023
Ended
13 Jan 2026
Type of study
Interventional
Treatments tested
  • AT ELANA
Record updated
22 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Age 18 years or older
  • Patients scheduled for bilateral AT ELANA 841P phacoemulsification cataract extraction or Femtosecond-Laser-Assisted-Cataract-Surgery (cataract grades of 1, 2, 3 on the LOCSIII scale) and IOL implantation (Cataract or PRELEX) with a maximum of 28 days between both implantations; Calculated IOL power within the limited IOL Diopter range of +15.0D to +27.0D
  • No visual acuity limiting pathologies other than cataract
  • Corneal Astigmatism of <1.0 D
  • Availability, willingness, and sufficient cognitive awareness to comply with examination procedures
  • Written informed consent for participation in the study and data protection

Who cannot take part

  • Use of systemic or ocular medication that might affect vision
  • Immediate Sequential Bilateral Cataract Surgery
  • Concurrent participation in another device investigation
  • Difficulty for cooperation (distance from their home, general health conditions)
  • History of acute or chronic disease, pathology, illness, or ocular trauma that would, in the surgeon's opinion, confound results (e.g., corneal pathology, OHT, glaucoma suspect, glaucoma, macular degeneration, cystoid macular edema, proliferative diabetic retinopathy, amblyopia, etc.)
  • Pupil abnormalities (non-reactive, tonic pupils, abnormal myosis or mydriasis, abnormally shaped pupils or pupils that do not dilate under mesopic/scotopic conditions)
  • Capsular or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g., pseudoexfoliation syndrome)
  • Corneal Astigmatism of ≥1.0 D
  • Visual field loss which has an impact on visual acuity
  • Patients with amblyopia, strabismus, forme fruste keratoconus or keratoconus
  • Cataract grades of 4, 5 or 6 on the LOCSIII scale
  • Surgeries with incision size of ≥2.75mm
  • Usage of contact lenses during participation

This trial has no sites in United States.

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn about the visual performance of a new multifocal intra-ocular lens in patients presenting for cataract or refractive lens exchange surgery. The main question it aims to answer is: What is the visual performance and patient satisfaction twelve months post-operatively? Participants will receive bilateral implantation of the investigational device, undergo post-operative assessments, and provide feedback on their overall visual satisfaction.

The group in the trial

  • Bilateral implantation of investigational deviceOther group

    Treatment: AT ELANA

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Multicentric Prospective Study on the Visual Performance of Patients Implanted With a Multifocal Intraocular Lens
Record updated
22 July 2026